INTRODUCTION
The renal biopsy is essential to distinguish among glomerular diseases with similar clinical presentations. Diverse pathogenetic mechanisms may produce a similar morphologic response. The primary role of the renal biopsy is to provide a diagnosis and information about disease activity and chronicity. Most of the glomerular injuries are thought to be immune-mediated. 1, 2 In the majority of cases, the inciting etiologic agents remain unknown with the exception of glomerulonephritis (GN) that are clearly induced by infections, such as post streptococcal and hepatitis C virus-induced cryoglobulinemic GN, and a few examples of drug-induced and cancer-associated GNs. 3, 4 Glomerular injury is usually mediated by the actions of multiple elements of both the innate and the adaptive immune systems, resulting in diverse clinical and pathologic manifestations. 5 The type of injury and the renal host response are important in defining the morphologic manifestations and in determining the clinical course of the patient.
ULTRASTRUCTURE OF GLOMERULUS
The layers (inner to outer) of glomeruli are a) Fenestrated endothelium; b) Glomerular Basement membrane; c) Podocytes (visceral epithelium with foot processes). These foot processes are embedded in lamina rara externa of the glomerular basement membrane and have filtration slits of 70-100nm dimension between the foot processes. The fourth component is parietal epithelium which lines Bowman's space and the last component is mesangial cells.
SITE OF GLOMERULAR INJURY
The major determinant of whether the patient presents with nephritic or with nephrotic syndrome is the site of glomerular injury. There are three major types of resident glomerular cells: epithelial cells, endothelial cells, and mesangial cells. Glomerular endothelial and mesangial cells come into direct contact with circulating factors like complement and inflammatory cells including neutrophils, macrophages, natural killer cells, and T cells. Immune complexes that form or deposit in the mesangial matrix or subendothelial space often result in glomerular inflammation and GN. Glomerular visceral epithelial cells or podocytes are the major barrier that restricts the filtration of negatively charged or large (>60 kDa) plasma proteins. Injury to podocytes leads to massive proteinuria and is often associated with the nephrotic syndrome. As podocytes are separated from the circulation by the glomerular basement membrane (GBM), subepithelial immune deposits that target podocytes seldom produce glomerular inflammation, and therefore there is little or no hematuria and no red blood cell casts.
In response to glomerular injury, there is an increase in glomerular permeability to macromolecules such as transforming growth factor-beta, fatty acids, proinflammatory markers of oxidant stress, and protein may result in toxicity to the mesangial matrix, causing mesangial cell expansion, inflammation, fibrosis, and glomerular scarring. Both the structural alterations and accompanying biochemical, cellular, and molecular changes seem to account for progressive renal scarring and loss of kidney function. 
CLINICAL MANIFESTATION OF RENAL DISEASE

EVALUATION OF PROTEINURIA
Average daily urinary protein excretion in adults is 80 mg/ day, with normal excretion considered to be <150 mg/day. Albumin represents approximately 15% of the daily urinary protein excretion in healthy people, with other plasma proteins (e.g., immunoglobulins, beta-2-microglobulin) and Tamm-Horsfall protein constituting the remaining 85%. Proteinuria varies in amount and may be transient or persistent. 6, 7 It is important to distinguish persistent and transient proteinuria. The common causes for transient proteinuria are fever, heavy physical exertion, urinary tract infection, orthostatic proteinuria and pregnancy. The presence of dipstick-positive proteinuria on 2 urine samples separated by 1 to 2 weeks indicates persistent proteinuria and warrants quantification and further evaluation. 8 If orthostatic proteinuria is suspected, the protein-to-creatinine ratio in a first morning voided urine specimen should be compared with the ratio from a random sample later in the day. The absence of proteinuria in the morning sample and presence in the daytime sample confirms orthostatic proteinuria. The presence of persistent proteinuria should prompt evaluation of kidney function by estimation of GFR from serum creatinine and/or collection of 24-hour urine for creatinine clearance. Urgent consideration is required in proteinuria due to renal vein thrombosis or features with RPGN.
INDICATION FOR RENAL BIOPSY
A kidney biopsy is required to make a definitive diagnosis that might affect treatment or provide information about disease progression or prognosis. A biopsy should be avoided when the potential risk to the patient exceeds any likely benefit from procuring kidney tissue. Indication for a renal biopsy is summarized in Table 1 . 9 Percutaneous renal biopsy for the detection of primary renal disease is generally not pursued in the following settings: 
The Biopsy Core
The specimen should be handled very carefully to avoid squeezing and compression, preferably by wooden sticks instead of forceps. A needle biopsy specimen should be divided under a dissecting microscope. This microscope allows for visualization and differentiation of the renal cortex and medulla. The medulla shows parallel structures DOI : 10.3126/jpn.v9i2.25664 
Hematuria
Presence of acanthocytes or red blood cell casts with an elevated Scr level or proteinuria
Proteinuria
Proteinuria > 1 g/d as measured on multiple visits with no clear comorbidity; proteinuria > 3 g/d in the absence of diabetes or a rapid increase in proteinuria even with diabetes; proteinuria < 3 g/d with an elevated Scr level with no clear comorbid conditions such as diabetes or hypertension
AKI
In the setting of ATI, persistent injury despite reversal of cause or if Scr did not return to baseline with 7-14 d of injury onset; in the setting of presumptive AIN, if there has been no resolution of injury despite removal of culprit medication
CKD
Rapid elevation in Scr level or new-onset hematuria or proteinuria
Abbreviations: AIN, acute interstitial nephritis; AKI, acute kidney injury; ATI, acute tubular injury; CKD, chronic kidney disease; Scr, serum creatinine.
Figure 1: Renal biopsy cores
(vasa recta and collecting ducts); on the other hand, the cortex appears irregular, and its glomeruli usually are visible as small red capillary conglomerates. In standard preparation, 2 biopsy cores are taken and divided for LM, IF and EM into the appropriate fixative. It needs two small (2mm) pieces with glomeruli for EM, a small (3-5mm) piece with glomeruli for IF, and the remaining tissue for paraffin sections for LM. If no dissecting microscope is available, the best method is to cut 1mm pieces from both ends of the biopsy specimen for EM and two 2mm pieces for IF and submit the rest for routine paraffin processing for LM. Lacking a dissecting microscope, the operator may elect to section each biopsy sample into halves for IF and LM after removing small sections of each for EM from ends. Biopsy cores should contain cortical tissue. Figure 1 demonstrates a method for dividing 2 cores for LM, IF and EM. 10
RENAL BIOPSY EVALUATION
Usually, one renal pathologist is involved in providing renal pathology services when the renal biopsy is <200/year. • Incubate the slides in Tris-EDTA buffer (pH9.0-9.2) at 37 0 C for 30 min.
• Take out the slides from jars and add proteinase K solution onto the section followed by incubation at 37 0 C for 5 min. • Incubate the slides in humidified chamber at room temperature for 1-2 hrs.
• Rinse the slides with PBS (pH7.2-7.4) for 5 min.
• Mount in aqueous mounting media (PBG, phosphate buffer glycerin)
• Examine the slide under a dark field ultraviolet microscope 
Electron Microscopsy
EM tissue is processed and embedded in a plastic, hard media, and thick sections are stained with Toluidine blue to identify the specific area to be cut for thin sections to be placed on a grid for EM examination. Typically 2 working days are needed to process and produce EM sections for ultrastructural examination.
The need for EM should be assessed on the basis of LM findings. If EM technical services are being provided remotely by a specialized diagnostic center, then the semi thin sections from the EM block and the digital EM images should be provided to the pathologist responsible for reporting the renal biopsy.
THE RENAL BIOPSY INTERPRETATION
The LM, IF and EM findings of renal biopsy should ideally be reported by the same pathologist. Reporting each in isolation may result in serious misdiagnosis. The biopsy report for non-neoplastic kidney diseases represents a complex integration of clinical data with LM, IF and EM findings.
Light Microscopy
Small samples are adequate for diffuse diseases. Large samples are needed for focal diseases. The minimum sample size for diagnosis varies greatly with the specific diagnosis; for instance, membranous glomerulonephritis can be diagnosed from a single glomerulus. The number of glomeruli required for native renal biopsy for adequacy is 15 to 20 glomeruli. For focal lesions involving a small number of glomeruli, 25 glomeruli may be needed. For renal allograft biopsies, a minimum of 8 glomeruli and two arteries are needed.
Four renal components (glomeruli, tubules, interstitium, and blood vessels) are evaluated sequentially. It should be decided which compartment of the kidney is the most severely involved (primary involvement) along with less prominent changes in other compartments (secondary involvement).
The authors recommend evaluating HE and PAS stained slides under low magnification moving slides back and forth at least seven times even if it appears unremarkable. The first component in the interpretation of glomerular disease is to access glomerular cellularity. Normocellularity is defined as no more than three cells in an individual glomerular mesangial region, away from the vascular pole. If the glomerular hypercellularity is severe and leads to closure of the glomerular capillaries, one has to decide whether the hypercellularity is within the glomerular tuft (intracapillary proliferative GN) or outside the glomerular tuft in Bowman space (extracapillary proliferative GN/crescentic GN). There is evidence that the hypercellularity can result not only from the proliferation of native glomerular cells (i.e., mesangial, endothelial, and epithelial cells) but also from infiltration of mononuclear and/or polymorphonuclear leukocytes.
Glomerular, tubular, and vascular relationships are important. The afferent arterioles perfuse the glomerulus directly, and the cortical tubules are supplied by post Because each LM pattern of GN can have many different causes with very different prognoses, recognition of the specific cause of the injury in a given specimen is very important. Spectrum of light microscopic morphology in response to injury is given in Figure 3 . 12
Tubules
• Acute injury, necrosis The numbers of glomeruli are counted. The glomerular and extra glomerular location, intensity, and pattern of staining are observed, recorded, and reported. Glomerular staining is categorized as mesangial or capillary wall or both. As with LM lesions, the distribution is described as focal or diffuse, and segmental or global. Capillary wall staining is described as granular, linear, or band-like. The location of the capillary wall staining in the GBM (intramembranous), between the GBM and the podocytes (subepithelial), or between the GBM and endothelial cells (subendothelial) sometimes can be discerned. Staining intensity, location/ pattern of staining for each antibody, and specify intensity scale (0-3+ or 0-4+)
Electron Microscopy
EM allows a detailed evaluation of the cellular and extracellular contents of each glomerular compartment and assessment of the thickness, contour, and integrity of the GBM and mesangial matrix. Abnormal deposits, such as electron-dense immune deposits, or organized fibrillary or microtubular deposits, can be detected in subepithelial, intramembranous, and mesangial locations. Ultrastructural abnormalities in GBMs include thickening, thinning, lamellation, and subendothelial electron-lucent expansion. Glomerular deposits with an organized (patterned) substructure are pathognomonic in some circumstances or at least narrow the differential diagnosis substantially. Abnormalities in cells can be readily detected, such as the effacement of podocyte foot processes seen with proteinuria or the swelling of endothelial cells seen with eclampsia/ preeclampsia and the thrombotic microangiopathies.
The schema for diagnosing immune-mediated glomerular diseases based on integration of IFM EM, serology, and other laboratory and clinical data is shown in figure 4 . 13 GNs are classified into the five principal groups as shown in figure 5 . 14 In general, placement within one class means that other classes of GN can be excluded and this can then guide one toward correct evaluation, diagnosis and management of the GN. While immune complex-mediated GN is most heterogeneous and contains many specific diseases, other groups such as ANCA-associated GN, antiglomerular basement membrane (GBM) GN, monoclonal Ig GN and C3 glomerulopathy are rather specific and in themselves point to the specific etiology of the GN.
Once the LM, IF and EM findings are collected, as well as relevant clinical data an integrated interpretation must be formulated and a diagnosis, rendered. For glomerular diseases, in particular, this diagnosis often includes both terms that describe the histologic pattern of injury seen by LM and terms that reflect findings by IF or EM. The diagnosis could be further modified by knowledge of findings in the patient not observed in the renal biopsy specimen, e.g. Henoch-Schönlein purpura nephritis with focal proliferative and sclerosing GN.
Basic format of kidney biopsy report is given below. 15, 16 (1) Specimen type: needle biopsy, wedge, etc.
(2) Diagnosis
Primary diagnosis
Disease process/pathogenic type (e.g., IgA nephropathy, lupus GN, ANCA GN, C3 GN)
Pattern of glomerular injury (e.g., mesangial proliferative, membranoproliferative, necrotizing/crescentic, and focal and segmental sclerosing)
Histologic scores or grade (e.g., Oxford/MEST for IgA nephropathy and ISN/RPS for lupus nephritis)
Additional features (e.g., degree of global glomerulosclerosis, IFTA, vascular sclerosis, clinical modifiers, such as cryoglobulin/clinical HCV, bacterial endocarditis/clinical, staphylococcal cellulitis/clinical) Secondary diagnoses (list; e.g., acute interstitial nephritis and diabetic glomerulosclerosis); these are not felt to be part of the primary disease (3) Comment/narrative Can be used for summarizing/clarifying morphologic basis of primary and/or secondary diagnoses or clinicopathologic correlations, providing prognostic information, discussing differential diagnosis, and providing appropriate references (4) Summary of clinical data
